1.67
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Market Closed
Volume | 0.00 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Best deals to access real time data! |
Small Cap Pro
Monthly Subscription
for only
|
Canna Trader Pro
Monthly Subscription
for only
|
Small Cap Basic
Monthly Subscription
for only
|
VAT not included
|
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Immune Therapeutics Inc (PK) | IMUN | OTCMarkets | Common Stock |
Price Change | Change Percent | Stock Price | Last Traded
![]() |
|
---|---|---|---|---|
0.00 | 0.0% | 1.67 | 07:50:36 |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
1.67 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
0 | 0.00 | - | 1.02 - 5.35 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
- | 0 | $ 1.67 | USD |
Immune Therapeutics Inc (PK) Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
$ 807.84k | 483.74k | - | $ - | $ - | - | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
39.99k | $ - | - | - | - |
Immune Therapeutics (PK) News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical IMUN Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 1.70 | 1.70 | 1.65 | 1.69 | 611 | -0.03 | -1.76% |
1 Month | 1.70 | 2.20 | 1.55 | 1.72 | 385 | -0.03 | -1.76% |
3 Months | 1.75 | 2.85 | 1.0301 | 1.99 | 2,687 | -0.08 | -4.57% |
6 Months | 1.75 | 2.90 | 1.0301 | 1.82 | 2,137 | -0.08 | -4.57% |
1 Year | 4.745 | 5.35 | 1.02 | 2.49 | 1,860 | -3.08 | -64.81% |
3 Years | 0.0047 | 7.99 | 0.0038 | 0.020705 | 1,102,494 | 1.67 | 35,431.91% |
5 Years | 0.0489 | 7.99 | 0.0027 | 0.0204323 | 984,157 | 1.62 | 3,315.13% |
Immune Therapeutics (PK) Description
Immune Therapeutics, Inc. is a biotechnology company developing and seeking to commercialize patented therapies in emerging nations that combat chronic, life-threatening diseases by stimulating or rebalancing the immune system. Our technology platform is based on two interrelated cytokine drug therapies-Low-Dose Naltrexone (LDN) and Methionine Enkephalin (MENK)-which work by triggering opioid receptors on immune cells to activate various cells of the immune system. |